CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net Income (Loss)	$ (28,656)	$ (12,449)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	303	287
Provision for expected credit losses	0	17
Stock-based compensation expense	2,804	1,357
Provision for excess and obsolete inventory	82	(23)
Provision for net realizable value of inventory	129
Change in fair value of warrant liabilities	12,450	4,139
Accretion of discount on short-term investments	(916)	(875)
Amortization of operating lease right-of-use asset	301	276
Loss on disposal of property and equipment		8
Changes in operating assets and liabilities:
Accounts receivable	2,936	(1,918)
Inventories	(2,621)	(2,407)
Prepaid expenses and other current assets	(1,620)	(1,061)
Other long-term assets	4	1
Accounts payable	(97)	410
Accrued expenses and other current liabilities	(5,273)	(231)
Operating lease liability	(281)	(224)
Deferred revenue	480	549
Net cash used in operating activities	(19,975)	(12,144)
Cash flows from investing activities:
Purchases of short-term investments	(142,935)
Purchases of long-term investments	(63,854)
Proceeds from maturities and redemptions of short-term investments	28,000	8,000
Proceeds on disposal of property and equipment		50
Purchases of property and equipment	(333)	(406)
Net cash (used in) provided by investing activities	(179,122)	7,644
Cash flows from financing activities:
Proceeds from the issuance of common stock, net of underwriting discounts, commissions and issuance costs	195,430
Proceeds from the issuance of common stock from private placement, net of issuance costs	15,591
Proceeds from stock option exercises	98	6
Net cash provided by financing activities	211,119	6
Net increase (decrease) in cash, cash equivalents and restricted cash	12,022	(4,494)
Cash, cash equivalents and restricted cash at beginning of period	30,532	26,666
Cash, cash equivalents and restricted cash at end of period	42,554	22,172
Supplemental disclosure of non-cash investing and financing information:
Purchases of property and equipment included in accounts payable	699	5
Purchases of property and equipment in accrued expenses and other current liabilities	10
Unrealized gain (loss) on short-term investments	25	(132)
Unrealized gain on long-term investments	150
Conversion of convertible preferred stock upon IPO	321,373
Conversion of warrants net exercise upon IPO	57,348
Reclassification of deferred offering costs to equity upon IPO	5,051
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	42,454	22,072
Restricted cash	100	100
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	$ 42,554	$ 22,172